BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21225533)

  • 1. [Current concepts of the pathogenesis of acquired middle ear cholesteatoma].
    Welkoborsky HJ
    Laryngorhinootologie; 2011 Jan; 90(1):38-48; quiz 49-50. PubMed ID: 21225533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of cholesteatoma.
    Maniu A; Harabagiu O; Perde Schrepler M; Cătană A; Fănuţă B; Mogoantă CA
    Rom J Morphol Embryol; 2014; 55(1):7-13. PubMed ID: 24715159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research.
    Kuo CL
    Laryngoscope; 2015 Jan; 125(1):234-40. PubMed ID: 25123251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of cytokeratins in retraction pocket cholesteatomas.
    Kim HJ; Tinling SP; Chole RA
    Laryngoscope; 2001 Jun; 111(6):1032-6. PubMed ID: 11404616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory.
    Sudhoff H; Tos M
    Am J Otol; 2000 Nov; 21(6):786-92. PubMed ID: 11078064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction pockets and attic cholesteatomas.
    Sadé J
    Acta Otorhinolaryngol Belg; 1980; 34(1):62-84. PubMed ID: 6162358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation].
    Bujía J; Holly A; Kim C; Schilling V; Kastenbauer E
    Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based review of aetiopathogenic theories of congenital and acquired cholesteatoma.
    Persaud R; Hajioff D; Trinidade A; Khemani S; Bhattacharyya MN; Papadimitriou N; Kalan A; Bhattacharyya AK
    J Laryngol Otol; 2007 Nov; 121(11):1013-9. PubMed ID: 17697435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune cell profile in invasive cholesteatomas: preliminary findings.
    Hussein MR; Sayed RH; Abu-Dief EE
    Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of cholesteatoma].
    Gersdorff MC; Debaty ME; Tomasi JP
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(3):115-9. PubMed ID: 17007181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired cholesteatoma pathogenesis: stepwise explanations.
    Louw L
    J Laryngol Otol; 2010 Jun; 124(6):587-93. PubMed ID: 20156369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
    Durko M; Kaczmarczyk D
    Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Middle ear cholesteatoma: present-day concepts of etiology and pathogenesis].
    Lesinskas E; Kasinskas R; Vainutiene V
    Medicina (Kaunas); 2002; 38(11):1066-71; quiz 1141. PubMed ID: 12532718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic cholesteatomatous otitis media: the histopathological and clinical aspects].
    Marcato P; Giuritti P; Pozzo T; Vitiello R; Valente G; Giordano C; Sartoris A
    Acta Otorhinolaryngol Ital; 1991; 11(5):465-70. PubMed ID: 1820721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.
    Suchozebrska-Jesionek D; Szymański M; Kurzepa J; Gołabek W; Stryjecka-Zimmer M
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):628-32. PubMed ID: 19128667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of retraction pockets in cholesteatoma development: an ultrastructural study.
    Akyildiz N; Akbay C; Ozgïrgïn ON; Bayramoglu I; Sayin N
    Ear Nose Throat J; 1993 Mar; 72(3):210-2. PubMed ID: 8482265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new experimental model of acquired cholesteatoma.
    Massuda ET; Oliveira JA
    Laryngoscope; 2005 Mar; 115(3):481-5. PubMed ID: 15744162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteatoma: a molecular and cellular puzzle.
    Albino AP; Kimmelman CP; Parisier SC
    Am J Otol; 1998 Jan; 19(1):7-19. PubMed ID: 9455941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
    Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
    Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.